Harrow Reports Substantial Q4 and Full-Year 2025 Revenue Growth

Published on March 3, 2026
NASHVILLE, Tenn.—Harrow (Nasdaq: HROW), a North American provider of ophthalmic disease management solutions, yesterday announced its financial results for the fourth quarter and year ended December 31, 2025. The company reported record Q4 revenue of $89.1 million, representing a 33 percent increase compared with the $66.8 million reported in the prior-year period. For the full year, total revenue reached $272.3 million, a 36 percent rise compared with the $199.6 million recorded in 2024, according to the announcement.
Continue reading on website
Other news

Eyecare Republic Makes Two Key Leadership Appointments to Support Member Brand Expansion

March 3, 2026
PLANO, Texas—Eyecare Republic (ECR), a nationwide network of independent optometrists, has announced two key leadership appointments as the organization prepares to launch its first member-exclusive brand in April. Jennifer Hogan has been named senior director of operations and membership and Graham Purdy will become chairman of ECR’s advisory board, according to the announcement. These two strate

Zeiss Vision Care, Medical Eyeglass Center Form Strategic Partnership

March 3, 2026
HEBRON, Ky.—Zeiss Vision Care, a leading global manufacturer of eyeglass lenses and ophthalmic instruments, announced today a strategic partnership with Medical Eyeglass Center (MEC), a nationally recognized, full-service optical dispensary management organization. The collaboration establishes Zeiss as the exclusive laboratory and service provider within MEC’s optical dispensary management organi